Jeff Yass’s Global Cord Blood Corporation CO Stock Holding History

Jeff Yass’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-18,300	Closed	-$54.7K	–	14263
2022 Q4	$54.7K	Hold	18,300	–	–	﹤0.01%	11340
2022 Q3	$55K	Buy	+18,300	New	+$45K	﹤0.01%	12142
2022 Q1	–	Sell	-10,700	Closed	-$45K	–	14644
2021 Q4	$45K	Sell	10,700 -32,300	-75%	-$137K	﹤0.01%	12607
2021 Q3	$201K	Sell	43,000 -71,800	-63%	-$352K	﹤0.01%	11474
2021 Q2	$613K	Buy	114,800 +104,700	+1,037%	+$548K	﹤0.01%	9092
2021 Q1	$46K	Hold	10,100	–	–	﹤0.01%	12054
2020 Q4	$37K	Buy	+10,100	New	+$38.8K	﹤0.01%	10815
2018 Q3	–	Sell	-11,200	Closed	-$106K	–	10916
2018 Q2	$106K	Sell	11,200 -28,400	-72%	-$272K	﹤0.01%	9019
2018 Q1	$404K	Buy	+39,600	New	+$405K	﹤0.01%	7055

Other funds holding CO

Natixis Advisors Boston, Massachusetts $88.9B AUM 38.03% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

UMB Bank Kansas City, Missouri $7.9B AUM 29.3% 1-Year Est. Return

Operose Advisors Milwaukee, Wisconsin $517M AUM 24.68% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Jeff Yass's CO Position: Q2 2023 in Review

Jeff Yass sold out of Global Cord Blood Corporation (CO) in Q2 2023, closing a stake of 13,333 shares — an estimated $39.8K sold.

Jeff Yass first reported a position in CO in Q2 2015 and held it in 20 quarters. The position peaked at $873K in Q2 2015. 6 funds tracked by Wall St. Rank hold CO as of Q2 2023.

Jeff Yass reported no remaining Global Cord Blood Corporation position as of Q2 2023 after selling out during the quarter.
Jeff Yass sold 13,333 Global Cord Blood Corporation shares in Q2 2023, an estimated $39.8K.
Jeff Yass first reported a position in Global Cord Blood Corporation in Q2 2015 and held it in 20 quarters.
Jeff Yass's Global Cord Blood Corporation position peaked at $873K in Q2 2015.
6 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.